Jody Cain | LHA Investor Relations |
Jerry Jabbour | Chief Executive Officer |
Terry Matkovits | Chief Development Officer |
Keith Kucinski | Chief Financial Officer |
Julian Harrison | BTIG |
Welcome to the Matinas BioPharma Second Quarter 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
Following management’s prepared remarks, we will hold a question-and-answer session. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the conference over to Jody Cain.